Caredx to present at the 2023 cantor global healthcare conference

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company will participate in the 2023 cantor global healthcare conference. caredx's management is scheduled to present at the 2023 cantor global healthcare conference on wednesday, september 27, 2023, at 7:20 a.
CDNA Ratings Summary
CDNA Quant Ranking